Skip to main content

Table 1 Demographic characteristics of participants (n = 84,602)

From: Trends in predicted 10-year risk for cardiovascular diseases among patients with type 2 diabetes in Thailand, from 2014 to 2018

Year

2014

2015

2018

Characteristics

n = 26,874

n = 26,554

n = 31,174

n (%)

n (%)

n (%)

Sex

 Male

8079 (30.1)

8451 (31.8)

10,205 (32.7)

 Female

18,795 (69.9)

18,103 (68.2)

20,969 (67.3)

Age (years)

 30–39

778 (2.9)

701 (2.6)

706 (2.3)

 40–49

3991 (14.9)

3561 (13.4)

3737 (12.0)

 50–59

9018 (33.6)

8948 (33.7)

10,154 (32.6)

 60–69

9929 (36.9)

10,049 (37.8)

12,462 (40.0)

 70–74

3158 (11.7)

3295 (12.4)

4115 (13.2)

 Mean ± S.D

58.4 ± 9.2

58.8 ± 9.1

59.3 ± 8.9

Geographic regions

 North

4010 (14.9)

4262 (16.1)

5416 (17.4)

 Central

7787 (29.0)

8755 (33.0)

10,172 (32.6)

 Northeast

10,057 (37.4)

8100 (30.5)

8877 (28.5)

 South

3593 (13.4)

3726 (14.0)

5200 (16.7)

 Bangkok

1427 (5.3)

1711 (6.4)

1509 (4.8)

Hospital level

 Regional hospital (S/A)

1810 (6.7)

2260 (8.5)

2032 (6.5)

 General hospital

3755 (14.0)

4243 (16.0)

4685 (15.0)

 Community hospital

21,309 (79.3)

20,051 (75.5)

24,457 (78.4)

Occupation

 Agriculturist

12,040 (44.8)

10,951 (41.2)

12,389 (39.7)

 Retirement

6454 (24.0)

6807 (25.6)

9199 (29.5)

 Employee

4744 (17.7)

4980 (18.8)

5740 (18.4)

 Private business

1417 (5.3)

1811 (6.8)

1998 (6.4)

 Government officer

1116 (4.2)

1310 (4.9)

1505 (4.8)

 Others

1108 (4.1)

695 (2.6)

343 (1.1)

Health scheme

 Univeral healthcare coverage

21,394 (79.8)

20,601 (77.6)

24,674 (79.1)

 Civil servant medical benefit

3822 (14.2)

4175 (15.7)

4649 (14.9)

 Social security

1248 (4.7)

1237 (4.7)

1433 (4.6)

 Others

361 (1.3)

541 (2.0)

418 (1.3)

Current smoker

1273 (5.0)

1162 (4.6)

1201 (3.9)

Hypertension

19,720 (73.4)

20,096 (75.7)

23,475 (75.3)

Dyslipidemia

18,401 (68.5)

19,307 (72.7)

21,793 (69.9)

Receiving anti-hypertensive medications

19,215 (71.5)

19,351 (72.9)

22,633 (72.6)

Receiving statin therapy

11,411 (58.8)

12,012 (60.9)

17,825 (68.5)

Diabetes duration (years)

 Mean ± S.D

7.1 ± 4.6

7.5 ± 4.7

8.0 ± 5.0

Body mass index (kg/m2)

 Mean ± S.D

25.7 ± 4.5

25.9 ± 4.6

26.0 ± 4.7

Systolic blood pressure (mmHg)

 Mean ± S.D

129.3 ± 15.7

131.2 ± 15.8

132.6 ± 14.9

Diastolic blood pressure (mmHg)

 Mean ± S.D

74.6 ± 9.9

75.1 ± 10.1

75.2 ± 10.0

Fasting plasma glucose (mg/dL)

 n (%)a

24,492 (91.1)

24,721 (93.1)

29,595 (94.9)

 Median (IQR)

143 (120–177)

143 (120–177)

143 (121–176)

Hemoglobin A1c (%)

 n (%)a

20,857 (77.6)

21,441 (80.7)

29,105 (93.4)

 Median (IQR)

7.6 (6.6–9.1)

7.6 (6.6–9.1)

7.6 (6.6–9.0)

LDL cholesterol (mg/dL)

 n (%)a

23,498 (87.4)

23,389 (88.1)

29,282 (93.9)

 Median (IQR)

106 (84–132)

105 (83–131)

102 (80–128)

HDL cholesterol (mg/dL)

 n (%)a

20,681 (77.0)

20,616 (77.6)

26,624 (85.4)

 Median (IQR)

45 (38–54)

46 (38–55)

47 (39–56)

Total cholesterol (mg/dL)

 n (%)a

21,882 (81.4)

22,004 (82.9)

28,004 (89.8)

 Median (IQR)

184 (158–215)

182 (156–213)

180 (154–210)

  1. ahave a laboratory testing, SD standard deviation